AWM Investment Company Inc. 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:41 pm Purchase | 2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC | AWM Investment Company Inc. | 2,387,500 7.700% | 2,387,500 (New Position) | Filing |
| 2024-02-14 3:42 pm Purchase | 2023-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | AWM Investment Company Inc. | 2,450,000 9.800% | 900,000 (+58.06%) | Filing |
| 2023-02-14 2:40 pm Sale | 2022-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | AWM Investment Company Inc. | 1,550,000 9.000% | -67,153 (-4.15%) | Filing |
| 2022-02-11 4:54 pm Purchase | 2021-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | AWM Investment Company Inc. | 1,617,153 9.990% | 1,617,153 (New Position) | Filing |
| 2022-02-11 4:20 pm Purchase | 2021-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | AWM Investment Company Inc. | 1,617,153 9.990% | 1,617,153 (New Position) | Filing |